Pharmacognosy intro
Evening Primrose's primary active compound is gamma-linolenic acid (GLA) at 7-14% of seed oil, an omega-6 essential fatty acid. The oil also contains linoleic acid (65-80%), oleic acid (5-12%), palmitic acid (6-10%), stearic acid (1-3%), and polyphenols (ellagitannins, catechins, gallic acid) in the seed coat. The PRIMARY mechanism is prostaglandin modulation: GLA converts to DGLA (dihomo-gamma-linolenic acid), then to PGE1 (prostaglandin E1), an ANTI-INFLAMMATORY prostaglandin that is vasodilatory, anti-platelet, anti-inflammatory, and modulates T-cell function. The critical insight is the delta-6-desaturase bypass: many women with hormonal dysfunction, diabetes, aging, zinc deficiency, or alcohol use have impaired delta-6-desaturase enzyme activity. Supplementing GLA directly BYPASSES this metabolic bottleneck. GLA incorporation into cell membrane phospholipids improves membrane fluidity and receptor function. It shifts eicosanoid production away from pro-inflammatory Series 2 prostaglandins (from arachidonic acid) toward anti-inflammatory Series 1 prostaglandins (from DGLA).